English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [913]
News [2612]
Articles [111]
Editorials [3]
Conferences [85]
elearning [27]
AACR 2025: Expert to share promising results on new immunotherapy approach in non-small cell lung cancer
AACR 2025: Expert to share promising results on new immunotherapy approach in non-small cell lung cancer
AACR 2025: Oral investigational agent zoldonrasib elicits objective responses in patients with KRAS G12D-mutated lung cancer
AACR 2025: Oral investigational agent zoldonrasib elicits objective responses in patients with KRAS G12D-mutated...
New cell therapy shows promising results in advanced tumour diseases
New cell therapy shows promising results in advanced tumour diseases
Towards understanding tumors in 3D
Towards understanding tumors in 3D
University effectively tests molecules capable of improving immunity or reducing inflammation of the tumour ecosyst
University effectively tests molecules capable of improving immunity or reducing inflammation of the tumour ecosyst
Liquid biopsy: A breakthrough technology in early cancer screening
Liquid biopsy: A breakthrough technology in early cancer screening
Researchers develop RNA blood test to detect cancers, other clues
Researchers develop RNA blood test to detect cancers, other clues
Outcomes for advanced hepatocellular carcinoma with pulmonary metastasis: Surgical vs. immunotherapy
Outcomes for advanced hepatocellular carcinoma with pulmonary metastasis: Surgical vs. immunotherapy
Study shows new immune boost could expand access to cancer immunotherapy
Study shows new immune boost could expand access to cancer immunotherapy
European Commission approves subcutaneous amivantamab for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
European Commission approves subcutaneous amivantamab for the treatment of patients with advanced EGFR-mutated non...
<12345...262>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top